Neurology®
The most widely read and highly cited peer-reviewed Neurology journal
Quick Search
Advanced Search
This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by FINCHAM, R. W.
Right arrow Articles by SCHOTTELIUS, D. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by FINCHAM, R. W.
Right arrow Articles by SCHOTTELIUS, D. D.
NEUROLOGY 1976;26:879
© 1976 American Academy of Neurology

Use of phenytoin serum levels in a case of status epilepticus

RICHARD W. FINCHAM, M.D., D. EUGENE WILEY, M.D. and DOROTHY D. SCHOTTELIUS, Ph.D.

From the Department of Neurology, University Hospitals, Iowa City, Iowa.

Serum anticonvulsant determinations made possible the identification of an unusual cause of status epilepticus and assisted with appropriate therapy in an epileptic patient with second-degree burns. The seizures were associated with a serum phenytoin concentration of 3.5 µg per milliliter. This suboptimal concentration of drug developed despite continuation of the patient's customary oral dose of phenytoin. The patient's response to intravenous phenytoin led to the conclusion that the unexpected decrement in serum anticonvulsant concentration was related to an impairment in absorption of that drug, possibly caused by the concurrent administration of oral oxacillin.

Requests for reprints should be addressed to Dr. Fincham, Department of Neurology, University Hospitals, Iowa City, IA 52242.

Received for publication June 23, 1975.